Mostrando 1 - 1 resultados de 1 para a busca 'Mikko A. I. Keränen', tempo de busca: 0.01s Refinar Resultados
  1. 1
    Gemtuzumab-Ozogamicin-Related Impaired Hemoglobin-Haptoglobin Scavenging as On-Target/Off-Tumor Toxicity of Anti-CD33 AML Therapy: A Report of Two Cases

    Gemtuzumab-Ozogamicin-Related Impaired Hemoglobin-Haptoglobin Scavenging as On-Target/Off-Tumor Toxicity of Anti-CD33 AML Therapy: A Report of Two Cases por Hanna L. M. Rajala, Veli-Jukka Anttila, Mikko Haapio, Mikko A. I. Keränen, Ulla Wartiovaara-Kautto, Riikka Räty

    Publicado em 2021-01-01
    Obter o texto integral
    Artigo

Ferramentas de busca: